Differentiation therapy

被引：95
作者：
Spira, AI [1 ]
Carducci, MA [1 ]
机构：
[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA
来源：
CURRENT OPINION IN PHARMACOLOGY | 2003年 / 3卷 / 04期
关键词：
D O I：
10.1016/S1471-4892(03)00081-X
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Differentiation therapy is an area of oncology that is in its infancy Theoretically, the concept of differentiation therapy involves turning a cancer cell 'off' biologically and reverting to a more 'benign' phenotype. Many agents have been studied over the past few years, with many already either in use clinically or showing future promise.
引用
收藏
页码：338 / 343
页数：6
相关论文
共 57 条
  • [31] 2-D
  • [32] Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo
    Jing, YK
    Wang, L
    Xia, LJ
    Chen, GQ
    Chen, Z
    Miller, WH
    Waxman, S
    [J]. BLOOD, 2001, 97 (01) : 264 - 269
  • [33] Angiogenesis in acute promyelocytic leukemia:: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid
    Kini, AR
    Peterson, LC
    Tallman, MS
    Lingen, MW
    [J]. BLOOD, 2001, 97 (12) : 3919 - 3924
  • [34] Impact of azacytidine on the quality of life of patients with myelodysplastic syndrome treated in a randomized phase III trial: A cancer and leukemia group B study
    Kornblith, AB
    Herndon, JE
    Silverman, LR
    Demakos, EP
    Odchimar-Reissig, R
    Holland, JF
    Powell, BL
    DeCastro, C
    Ellerton, J
    Larson, RA
    Schiffer, CA
    Holland, JC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2441 - 2452
  • [35] Kubota T, 1998, CANCER RES, V58, P3344
  • [36] Role of the histone deacetylase complex in acute promyelocytic leukaemia
    Lin, RJ
    Nagy, L
    Inoue, S
    Shao, WL
    Miller, WH
    Evans, RM
    [J]. NATURE, 1998, 391 (6669) : 811 - 814
  • [37] Arsenic trioxide-induced apoptosis in myeloma cells:: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL
    Liu, Q
    Hilsenbeck, S
    Gazitt, Y
    [J]. BLOOD, 2003, 101 (10) : 4078 - 4087
  • [38] Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
    Marks, PA
    Richon, VM
    Rifkind, RA
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (15): : 1210 - 1216
  • [39] Matsui WH, 2002, CELL GROWTH DIFFER, V13, P275
  • [40] Miller WH, 2002, CANCER RES, V62, P3893
123456